PER 1.23% 8.0¢ percheron therapeutics limited

should create some interest, page-3

  1. 165 Posts.
    Well, that could be due because ANP was expecting more than what the partner was offering. Possibly, after the Phase 2 trials are complete and hopefully succesful, the partner will return with confidence shell out what ANP are asking.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.